[go: up one dir, main page]

GB2055811B - Prostacyclin derivatives - Google Patents

Prostacyclin derivatives

Info

Publication number
GB2055811B
GB2055811B GB8021459A GB8021459A GB2055811B GB 2055811 B GB2055811 B GB 2055811B GB 8021459 A GB8021459 A GB 8021459A GB 8021459 A GB8021459 A GB 8021459A GB 2055811 B GB2055811 B GB 2055811B
Authority
GB
United Kingdom
Prior art keywords
prostacyclin derivatives
prostacyclin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8021459A
Other versions
GB2055811A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/054,720 external-priority patent/US4225507A/en
Priority claimed from US06/054,811 external-priority patent/US4225508A/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB2055811A publication Critical patent/GB2055811A/en
Application granted granted Critical
Publication of GB2055811B publication Critical patent/GB2055811B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB8021459A 1979-07-05 1980-07-01 Prostacyclin derivatives Expired GB2055811B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/054,720 US4225507A (en) 1979-07-05 1979-07-05 19-Hydroxy-19-methyl-PGI2 compounds
US06/054,811 US4225508A (en) 1979-07-05 1979-07-05 19-Hydroxy-PGI2 compounds

Publications (2)

Publication Number Publication Date
GB2055811A GB2055811A (en) 1981-03-11
GB2055811B true GB2055811B (en) 1983-06-02

Family

ID=26733395

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8021459A Expired GB2055811B (en) 1979-07-05 1980-07-01 Prostacyclin derivatives

Country Status (6)

Country Link
CH (1) CH645369A5 (en)
DE (1) DE3024723A1 (en)
FR (1) FR2460944B1 (en)
GB (1) GB2055811B (en)
IT (1) IT1131550B (en)
NL (1) NL8003829A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2048254B (en) * 1979-04-02 1983-05-25 Upjohn Co 19,20 -didehydro-19-hydroxy and 19-oxo-prostaglandin derivatives
DE3035713A1 (en) * 1980-09-22 1982-04-29 F. Hoffmann-La Roche & Co. AG, 4002 Basel 6,9-Epoxy 15-hydroxy prost-13-enoic and prostanoic acid derivs. - are antisecretories, bronchodilators, blood platelet aggregation inhibitors, antiulcer and antihypertensive cpds.

Also Published As

Publication number Publication date
NL8003829A (en) 1981-01-07
CH645369A5 (en) 1984-09-28
GB2055811A (en) 1981-03-11
DE3024723A1 (en) 1981-01-15
FR2460944B1 (en) 1987-05-07
IT1131550B (en) 1986-06-25
IT8023142A0 (en) 1980-06-30
FR2460944A1 (en) 1981-01-30

Similar Documents

Publication Publication Date Title
GB2055813B (en) Aminoalkylbenzene derivatives
GB2054560B (en) Benzylimdiazole derivatives
GB2058765B (en) Deformyltylosin derivatives
GB2043639B (en) 3-optionally substituted methyl-2-penem derivatives
NZ193800A (en) 3-vinylcephalosporin derivatives
NZ193799A (en) 3-vinyl-cephalosporin derivatives
GB2046734B (en) 7-(-oximino-pyrazolyl(-acetamido)-cephen derivatives
GB2055818B (en) 3-methyleneazetidine derivatives
GB2056452B (en) Halovincamone derivatives
MY8500273A (en) Pyrrlidine derivatives
GB2052493B (en) Imidazobenzodiazepine derivatives
GB2065111B (en) Decaprenylamine derivatives
GB2053899B (en) Terahydrophthalamide derivatives
GB2062464B (en) Eburnamenine derivatives
GB2055368B (en) E-homoeburnane derivatives
HK55483A (en) Isopropylamino-pyrimidine derivatives
GB2050377B (en) Pyrazinoquinoxaline derivatives
GB2059954B (en) 1-phenethylimidazole derivatives
GB2055811B (en) Prostacyclin derivatives
GB2043064B (en) Oximidazoquinoxaline derivatives
GB2065110B (en) Decaprenylamine derivatives
GB2065109B (en) Decaprenylamine derivatives
GB2042508B (en) 3-alkoxy-penem derivatives
JPS55133354A (en) Prostaglandin derivatives
GB2122186B (en) Oxapenem derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee